Quest Diagnostics (DGX) EPS (Basic) (2009 - 2026)

Quest Diagnostics has reported EPS (Basic) for 14 years, with the latest figure at $2.92 in Q2 2026.

• Quarterly EPS (Basic) rose 13.91% year-over-year to $2.92 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.77 (up 13.23% YoY) and the FY2025 annual result came in at $9.05, up 11.31% from the prior year.
• EPS (Basic) improved to $2.92 in Q2 2026 per DGX's latest filing, from $2.36 in the prior quarter.
• Over five years, EPS (Basic) peaked at $2.92 in Q2 2026 and troughed at $0.97 in Q4 2022.
• A 5-year average of $2.14 and a median of $2.13 in 2023 frame the typical range for EPS (Basic).
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 68.62% in 2022, then jumped 80.56% in 2023.
• Over 5 years, EPS (Basic) stood at $0.97 in 2022, then surged by 80.56% to $1.76 in 2023, then increased by 18.32% to $2.08 in 2024, then grew by 7.79% to $2.24 in 2025, then jumped by 30.12% to $2.92 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $2.92, $2.36, and $2.24 for Q2 2026, Q1 2026, and Q4 2025 respectively.